Eikon Therapeutics, Inc. Common Stock

NASDAQ: EIKN · Healthcare · Biotechnology

PublicHQ Millbrae, CA · San MateoCIK 0001861123Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 52

v0.1 · 5/100 weight · pillars only

↑ workforce scale, market scale · ↓ listing tenure, filing timeliness

Methodology →

Revenue TTM

—

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

—

Employees

384

as of 2026-08-02

Market cap

$498.6M

as of 2026-08-02

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Eikon Therapeutics, Inc. Common Stock’s financial profile?

Eikon Therapeutics, Inc. Common Stock has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

Zura Bio Limited——MapLight Therapeutics, Inc.——Nuvectis Pharma, Inc.——Kyverna Therapeutics, Inc.——Cabaletta Bio, Inc.——Rezolute, Inc.——

Neighbors

San Mateo →

Meta Platforms, Inc.$201.0B86A Gilead Sciences, Inc.$29.4B87A Equinix, Inc.$9.2B74B Robinhood Markets, Inc.$4.5B67B Electronic Arts Inc.$7.5B82B+Revolution Medicines, Inc.$053D

Key facts

CEORoger Perlmutter

SectorHealthcare

IndustryBiotechnology

HeadquartersMillbrae, CA

ExchangeNASDAQ: EIKN

Employees384

IPO date2026-02-05

Latest filings

8-K2026-08-14 8-K2026-08-13 10-Q2026-08-13 8-K2026-08-03 8-K2026-06-10 8-K2026-06-01 8-K2026-05-11 10-Q2026-05-11

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.